Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × capmatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Melanoma 3 Lung Neoplasms 2 Adenocarcinoma of Lung 2 Noonan Syndrome 6 1 Neoplasm Metastasis 1 Malignant Non-small Cell Neoplasm of Lung Stage IV 1 Liver Neoplasms 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡